Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study
(NYSE/TSX: BHC) is a global company whose mission is to improve peoples lives with our health care products
Nadkarni, P., Chepurny, O
Biomarker assessmentincluding serum glutathione, reduced vs
To see more articles like this, follow Komodo Health on LinkedIn, YouTube, or X, and visit our Resources Hub.
Kanwal F, Kramer JR, Li L, et al
US$ 20.71
US$ 29.67
US$ 25.75
US$ 26.37
US$ 20.26
US$ 20.90
US$ 26.08
US$ 24.17
